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Wound healing properties and 
antimicrobial activity of platelet-
derived biomaterials
Aref Shariati1, Alireza Moradabadi2,3, taher Azimi4 & ehsanollah Ghaznavi-Rad2,3*
We analyzed the potential antibacterial effects of two different PdB against methicillin-resistant S. 
aureus and P. aeruginosa. The third-degree burn wound healing effects of PdB was also studied. Blood 
samples were obtained from 10 healthy volunteers and biological assays of the PdB were performed 
and the antimicrobial activity against MRSA and P. aeruginosa was determined using disk diffusion 
(DD), broth microdilution (BMD), and time-kill assay methods. 48 Wistar albino rats were burned and 
infected with MRSA. Two groups were injected PdB, the control groups were treated with plasma 
and received no treatment respectively. In the next step, the rats were euthanized and skin biopsies 
were collected and histopathologic changes were examined. The results of DD and BMD showed that 
both PdB performed very well on MRSA, whereas P. aeruginosa was only inhibited by F-PdB and was 
less susceptible than MRSA to PdBs. The time-kill assay also showed that F-PdB has an antibacterial 
effect at 4 hours for two strains. Histopathological studies showed that the treated groups had less 
inflammatory cells and necrotic tissues. Our data suggest that PdB may possess a clinical utility as a 
novel topical antimicrobial and wound healing agent for infected burn wounds.
Among the traumatic injuries, burns are the main factor of mortality that causes structural and functional defi-
ciencies in numerous organ systems. So today, despite many advances in infection control and wound healing, 
burn wound infection causes 60% of deaths in burned patients and 300,000 deaths worldwide each year1,2. Burns 
damage skin integrity and weaken cellular and humoral immunity. Necrotic tissues also reduce the presence 
of immune cells in the burned area and facilitate the penetration of pathogens into the underlying tissues and 
promote their spreading3,4. Burn wounds are highly susceptible to infection due to the issues mentioned above. 
Therefore, as the burn sites are colonized with microorganism the burn wound invasive infections such as sep-
sis may occur. Methicillin-resistant S. aureus (MRSA) among gram-positive and Pseudomonas aeruginosa (P. 
aeruginosa) among gram-negative bacteria are predominant pathogens in burn wound infection5,6. S. aureus 
invades eschar, penetrates subcutaneous and unburned tissues and may create abscesses with different sizes. 
These abscesses protect S. aureus against host immunity and antibiotics and provide the conditions for entry 
of this bacterium into the bloodstream7. The subsequent development and use of broad-spectrum antibiotics 
effective against S. aureus resulted in the emergence of gram-negative organisms, particularly P. aeruginosa, as the 
predominant organisms causing invasive burn wound infections in burn patients8,9. It is worth noting that, the 
intrinsic and acquired properties such as efflux pumps and reduction of the permeability of the outer membrane 
proteins have created a high-level antibiotic resistance in P. aeruginosa, which has limited the use of antibiotics 
like fluoroquinolones, β-lactams, and carbapenems to control burn wound infections10,11. platelets are cells that 
play an important role in primary coagulation. However, platelets also absorb monocytes and macrophages after 
activation, therefore; platelets also play a role in secondary immunity12,13. Platelet granules contain antimicrobial 
peptides and growth factors such as platelet-derived growth factor, transforming growth factor (TGF), vascular 
endothelial growth factor (VEGF) and insulin-like growth factor (IGF) that affect the migration and binding of 
immune cells14,15. Furthermore, platelets cause skin cell regeneration, angiogenesis, collagen, and fibroblastic 
production that makes the platelets as a good candidate for wound healing16. But, due to immunologic reactions, 
the use of platelets has been restricted16. Platelets can be easily separated from the blood by centrifugation. Then, 
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their granule content can be released by calcium chloride or physical methods group such as freeze-unfreeze 
technique. Therefore, in this case not only the immunological responses to the platelets are prevented, but also the 
antimicrobial activity and wound healing process are enhanced17,18. Therefore, the purpose of present study was 
to evaluate the effect of platelet derived biomaterials as a blood-extracted biomaterial on P. aeruginosa and MRSA 
in order to find a new strategy for inhibiting these bacteria and burn wound healing.
Result
Antimicrobial susceptibility. The results of the Kirby-Bauer disk diffusion (DD) method showed that the 
F-PdB had a good inhibitory effect on MRSA (1 mm), while the CaCl2-PdB had a less inhibitory effect (0.5 mm). 
On the other hand, results showed that none of the PdBs were able to inhibit P. aeruginosa growth and no inhi-
bition zone was observed for this bacterium. Due to the lack of proper distribution of the PdB in DD, broth 
microdilution methods were used and CaCl2-PdB and F-PdB were prepared in different dilutions (ranging from 
1:2 to 1:2048) in wells. Both CaCl2-PdB and F-PdB were able to inhibit the growth of MRSA at the dilution of 1:2. 
Furthermore, F-PdB had an inhibitory effect on P. aeruginosa at its highest concentration (1:2), while CaCl2-PdB 
could not inhibit bacterial growth. It should be noted that the PdBs could be distributed in the microdilution 
method more than the DD and furthermore, the acidity and pH can also affect the antimicrobial activity of 
PdBs19, the inhibitory effect on P. aeruginosa was found in this method as opposed to the DD. Control wells 
(Plasma, CaCl2, and PBS) did not show any inhibitory effect on the tested concentrations, and no growths were 
observed in wells containing merely CaCl2-PdB, F-PdB and, culture medium. This indicated that the PdBs were 
not contaminated.
Time-kill assay. The results of this method showed that both CaCl2-PdB and F-PdB were able to reduce the 
number of MRSA bacteria compared to the control group. The highest decrease in the number of colonies was 
observed in the first 4 hours (1.5 Log 10) and there was no significant difference between the two PdB groups 
(P < 0.05). By contrast, P. aeruginosa was less susceptible to PdB than the MRSA and the bacterial population 
was reduced only by the F-PdB (0.4 log10), whereas CaCl2-PdB did not inhibit the growth of P. aeruginosa. As 
the bacteria increased in number after 8 hours, again, none of the extracts showed a bactericidal effect. Since the 
inoculums were reduced between 0 and 3 log10 CFU/ml (Fig. 1), they showed a bacteriostatic effect20.
cacl2-PdB and F-PdB effects on the bacterial burden in MRSA infected burn wounds. The in 
vivo evaluation of antimicrobial properties of CaCl2-PdB and F-PdB against MRSA was performed by homoge-
nizing infected burn wounds and quantifying the present CFUs in tissue on days 3 and 7 (Fig. 2A,B, respectively). 
The wounds treated by CaCl2-PdB and F-PdB significantly showed a decrease in bacterial counts compared to the 
control group (infected, untreated group) (p ≤ 0.05). However, CaCl2-PdB and F-PdB antimicrobial effects did 
not differ significantly from each other (p > 0.05). Both of the PdBs decreased the number of bacteria on days 3 
and 7 compared to the control group (which did not receive any treatment).
Histological evaluation of wound healing. In comparison to the control group, the treated group 
demonstrated a more accelerated wound healing process in the rats (Fig. 3). Moreover, the qualitative assessment 
showed that in the wounds treated by F-PdB and CaCl2-PdB the number of inflammatory cells was reduced. 
This phenomenon causes new angiogenesis, higher collagen deposition and reepithelization earlier in the treated 
groups than the control group (Fig. 4). Histopathologic examinations on specimens obtained from the rats of dif-
ferent groups on day 14 showed that the PdBs treated groups had a better wound healing than the control group 
that received no treatment and the rats treated with plasma. It is noteworthy that both PdBs accelerated matura-
tion and formation of the epidermis compared to the control group which has thinner neo-epidermis, whereas 
inflammatory granulation tissue, inflammation, and cell aggregation were also present in smaller amounts in 
PdB-treated rats. An increased amount of collagen and a reduction in necrotic tissue caused by burns were also 
observed in the PdB-treated groups. It should be noted that greater collagen deposition and organization were 
Figure 1. Antimicrobial activity of F and CaCl2-PdB against (A) MRSA and (B) P. aeruginosa in time-kill assay 
method compared with the control (initial inoculums at time 0).
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Figure 2. Wound bacterial burden on day 3 (A) and day 7 (B) in mice infected intradermally with 5 × 108 
cells MRSA was determined by the amount of CFU growth (n = 5 wounds per group). The bacterial burden of 
plasma, CaCl2-PdB, and F-PdB treated wounds in both bacteria were significantly lower than untreated, but 
no significant differences were observed between two the PdBs. Error bars denote SEM. *p ≤ 0.05, ns p > 0.05 
(CFU; colony forming unit).
Figure 3. Representative images of wound healing from days 1–14. Subcutaneously administration of F-PdB 
and CaCl2-PdB decreased eschar size and qualitatively accelerated healing compared to control groups (infected 
control and plasma treated). Scale bar = 5 mm.
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seen in the groups treated with F-PdB and CaCl2-PdB than in the two control groups, although there was no 
significant difference between the two treatment groups (Fig. 5). Furthermore, an increase in angiogenesis that 
indicates the proliferative phase of healing was observed in the F and CaCl2-PdB treated groups. It should be 
noted that the plasma-treated group did not undergo platelets activation and was used as the control. The results 
showed that plasma did not have any effect on reducing the number of MRSA and wound healing. Besides, there 
was no difference in collagen production, reduction of inflammatory cells and angiogenesis between the F-PdB 
and CaCl2-PdB treated groups.
Discussion
The mechanism by which the platelets inhibit the growth of microorganisms, reduce skin infections and enhance 
wound healing still remains elusive. Therefore, scientific studies about the applications of these preparations are 
relatively scarce21.Various factors such as platelets antimicrobial peptides (e.g. RANTES), myeloperoxidase, plate-
lets factor-4, connective tissue activating peptide III, platelet α-granules components and the high role of platelets 
in innate immunity are major factors inhibiting the growth of microorganisms21,22. Very few studies have evalu-
ated both antimicrobial and wound healing properties of a PdB, so this has limited the clinical translatability of 
those findings. Therefore, in the currents study, two different methods were used to activate platelets (CaCl2-PdB 
and F-PdB) and investigated their antimicrobial activity; in addition, these biomaterials were also tested for the 
healing of burn wounds. S. aureus and P. aeruginosa, two of the major pathogens isolated from burn wound 
infections, readily reach the bloodstream due to their different virulence factors and cause the death of the patient 
after septicemia. Furthermore, due to the emergence of antibiotic resistance, today, control of these bacteria has 
become very important10. The results of our DD and MIC methods showed that the PdB performed very well on 
MRSA but the results were different for P. aeruginosa and only F-PdB had an inhibitory effect on this bacterium. 
The reason for the differences in the sensitivity of different microorganisms to platelets antimicrobial peptides is 
not well understood, but it seems that the phenotypic difference of infecting bacteria is one of the main factors23. 
Previous studies have suggested that decreased sensitivity of S. aureus to antimicrobial agents of platelets may 
be related to reducing transmembrane potential, mutations in genes that encode proteins involved in the gen-
eration of the proton motive force or an increase in membrane fluidity20,24. Nevertheless, it seems that the more 
resistance of P. aeruginosa compared to S. aureus is further depended on differences in cell membrane charge and 
composition that reduces the interaction of platelet antimicrobial agents with the cell surface of gram-negative 
bacteria25. However, specialized methods such as bacterial cell surface imaging using electron microscopy after 
interaction with platelets are needed for a better understanding of these mechanisms and it may be possible to 
Figure 4. Histological analysis of wound tissue from day 14 using hematoxylin and eosin (H&E) (magnification 
10× , and 40×). (A,D and G) compared the epidermis and the extracellular matrix which is thinner in (A) 
(untreated control wounds) compared to (D and G) (freeze or CaCl2-PdB treated wound). (B,E and H) 40× 
magnification of the Histologic wound shows the separated epidermis in B (untreated control wounds) and 
new angiogenesis in (E and H) (freeze or CaCl2-PdB treated wound). (C,F and I) 40× magnification of the 
Histologic wound shows the inflammation and cell aggregation in (C) (untreated control wounds) and collagen 
production (F and I) (freeze or CaCl2-PdB treated wound).
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overcome cell membrane charge by using different ways of activating Platelets. This has demonstrated well in 
Aniytau et al. study that has investigated the effect of plasma rich in growth factors obtained in 5 different for-
mulations on methicillin-resistant and susceptible S. aureus and S. epidermidis. The results of their study showed 
that unlike the other strains, only methicillin-sensitive S. epidermidis were not well inhibited by plasma rich in 
growth factors while there was no plausible reason for this20. In another investigation, the antimicrobial effect of 
platelet-poor plasma, platelet-rich plasma, platelets gel, and solvent/detergent-treated platelets lysate from two 
donors on various gram-positive and gram-negative pathogens showed that Escherichia coli was inhibited well, 
but none of the plasma and platelets materials showed antimicrobial activity against Enterobacter cloacae, Bacillus 
cereus, Bacillus subtilis, and S. epidermidis21. Previous studies have shown that different platelets factors such 
as platelets-derived growth factors (PDGFs), TGF, VEGF, and IGF have an important role in the proliferation 
and survival of mesenchymal cell lineages and tissue repair. So, the present study aimed to evaluate the role of 
PdB in burn wound healing26,27. In addition to evaluate the antimicrobial activity, our results showed that PdB 
can also heal burn wounds. Collagen production, decreased necrotic tissue, re-epithelialization, and increased 
neovascularization was seen more in the PdB-treated groups compared with the control group. When platelets 
are activated by CaCl2 or freeze/unfreeze method, degranulation of platelet alpha granules occurs and growth 
factors release28,29. Furthermore, the platelet-derived endothelial cell growth factor is a stimulant for the collagen 
deposition also a chemotactic factor for macrophage, neutrophils, and monocytes29. Moreover, this factor regu-
lates the wound-healing process by secreting additional growth factors, such as tumor necrosis factor-a (TNF-a), 
basic fibroblast growth factor (bFGF) and triggers vessel proliferation by VEGF, PDGF, and bFGF30,31. Therefore, 
the better antimicrobial performance of PdB in the in vivo than in vitro conditions relies on the high impact of 
Figure 5. Fluorescent staining of collagen type I. The wound collagenization rate of rat skin samples which were 
immunolabelled with the antibody against collagen type I was measured on day 14. Wounds treated with F-PdB 
and CaCl2 showed greater collagen deposition and organization compared to the control groups (P < 0.05). The 
blue fluorescence represents DAPI nuclear-staining which confirms the presence of the cells. The percentages 
of the cell or tissue visual expression were measured using image j software. Scale bars are 50 µm. The statistical 
significance was measured by the Kruskal Wallis test and data are presented as mean ± SEM.
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PdB on the intense inflammatory response, release of soluble mediators, homing of circulating cells to damaged 
tissues which control infection, and wound healing26. Henderson and his colleagues reported that autologous 
platelet gel can heal wounds in pigs by the production of the extracellular matrix, fibroblastic proliferation, and 
collagen32. Umit Ozcelik et al. reported that PRP reduced inflammatory cell infiltration and had an effective role 
in burn healing after partial-thickness burn injury, which could be used in future studies for human wounds15. 
But they reported that PRP had no effect on fibroblast development, collagen production, vessel proliferation, or 
epithelization. The results of another study showed that PRP accelerated wound closure and reduced the num-
ber of inflammatory cells in deep second-degree burns and deep second-degree burns associated with diabetes 
mellitus but not in the third-degree burns33. Previous studies have used various approaches, including the use 
of nanoparticles to control burn wound infections25,34. These substances can have side effects on the eukaryotic 
cells, so the use of nanoparticles is limited whereas no side effects have been reported for platelet biomaterials. 
Besides, PdBs accelerate tissue healing and improve the efficiency of tissue repair following injury in a safe, relia-
ble, and economical manner25,34. In the present study, the antibacterial effect of PdB on MRSA and P. aeruginosa 
was investigated furthermore in vitro and in vivo effects were compared. Due to the good healing effect of PdB on 
burn wounds, this product can be used to make wound dressings to form a barrier against fluid loss and micro-
organism contaminations. Moreover, it improves wound healing by increasing the cells in the area, and allows 
vessel proliferation, keratinocyte adhesion, and differentiation. Finally, it should be noted that a wide range of 
microorganisms, including bacteria (coagulase-negative staphylococci, Enterococcus spp, Klebsiella pneumoniae, 
Serratia marcescens, Enterobacter spp. Proteus spp. and Acinetobacter spp), fungi (Candida spp., Aspergillus spp., 
Fusarium spp.) and viruses (herpes simplex virus, cytomegalovirus, varicella-zoster virus), are effective in burn 
wound infections, and the antimicrobial activity of PdBs on these microorganisms also should be assessed.
Methods and Materials
ethics statements. All experimental protocols and procedures for animal experimentation (rats) were car-
ried out in accordance with relevant guidelines and regulations and were approved by the Ethics Committee on 
Animal Research of Arak University of Medical Science (protocol number IR.ARAKMU.REC.1397.275).
platelet-rich plasma and plasma-derived biomaterial preparation. In this study, for preparing 
platelet-rich plasma (PRP) the expired human platelet products were used. All methods involving human blood 
products obtained from a blood bank were carried out in accordance with relevant guidelines and regulations. It 
should be noted that for the preparation of PdBs, we used expired human platelet products, so there was no ethi-
cal problem. 50cc of whole blood (blood and sodium citrate) was centrifuged at 1000 g for 10 minutes. The plasma 
rich fragment (PRF) was obtained from the supernatant of whole blood and was prepared as a blood product in 
the blood bank center. For enrichment of the PRF, it was centrifuged at 1500 rpm for 15 minutes to precipitate the 
platelets. The platelet-poor plasma (PPP) was prepared by separating the supernatant and pipetting it in a separate 
tube. PRP, on the other hand; remained in the centrifuged tube with the platelet concentration of 2500000 per 
microliter. During the preparation of PRP, samples were separated using Pasteur pipette and the count of platelet 
in PRP was measured using a cell counter. Noteworthy, a serial dilution of the platelet was used in the counting 
process to avoid aggregation in the cell counter. Platelet-derived biomaterial (PdB) was prepared by freezing and 
thawing platelet to disrupt the platelets membrane and to release its internal contents. For this purpose, prepared 
PRP was stored at −70 °C for 30 minutes then thawed in a 37 °C water bath for another 30 minutes. The freezing 
and thawing stage was repeated for 4 times. Finally, the suspension was centrifuged at 300 rpm for 15 minutes to 
remove the platelet lysate bodies. The supernatant, “freeze- PdB” (F-PdB), which was free of the platelet bodies 
was separated using a Pasteur pipette. Using CaCl2 as a platelet activator was another way to prepare CaCl2-PdB 
(CaCl2-PdB) in this study. For this purpose, PRP which was prepared in the prior stage was stored at 37 °C for 
30 minutes then an equal volume of CaCl2 (25 millimolar) was added to activate the platelets. Finally, the sus-
pension was centrifuged at 300 rpm for 15 minutes to remove the platelets remaining bodies and the supernatant 
which was free of the platelet bodies called “CaCl2-PdB” was separated using a Pasteur pipette35,36.
Bacterial strains and growth conditions. P. aeruginosa and MRSA were collected from patients’ wounds 
and the isolates were grown in brain heart infusion (BHI) broth medium overnight. Then, the bacteria were 
transferred to a fresh culture medium and incubated at 37 °C until reaching the mid-logarithmic phase. The sub-
cultures were centrifuged at 1,000 g for 15 min, the supernatant was discarded and the bacterial pellet was washed 
twice with sterile saline and resuspended in cold PBS to achieve a concentration of approximately 108 CFU/ml. 
The bacterial suspension was kept on ice until further use37,38.
Bacteria growth inhibition by disk diffusion method. Both isolates grown in agar were dissolved in 
sterile saline solution and the spectrophotometer measurement of the solutions at 600 nm showed a light absorp-
tion value of 0.3 units which indicated more than 108 CFU/ml of the bacteria in the solution. After making bacte-
ria stock solutions, both bacteria were cultured on a Muller Hinton agar (MHA) medium, afterward, disks soaked 
with approximately 30 µL of PdB (F-PdB and CaCl2-PdB) and plasma (as the control) were placed on the MHA 
medium. The plates were incubated overnight at 37 °C and the results of growth inhibition surrounding the discs 
observed visually. The size of the inhibition zone was rated based on the following criteria: no inhibition zone, 
inhibition zone of 0.5, 0.5–1, and greater than 1 mm21,37.
Determination of antibacterial activity by microdilution broth. The minimum inhibitory concen-
tration (MIC) of PdB was determined by the standard broth microdilution method using Mueller-Hinton broth 
(MHB) and custom- made 96-well plates. After seeding bacteria in trypticase soy agar, for each isolates a sus-
pension of bacteria in the growth medium of MHB was prepared with an optical density equal to 0.5 McFarland 
(1 × 108 CFU/mL). Using proper dilution, a concentration of 1 × 105 CFU/mL was prepared. Afterward, 10 μl 
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of each suspension was poured into a 96-wells microplate containing 100 μl of MHB and serial 2-fold dilution 
(ranging from 1:2 to 1:2048) of each PdB. For the positive control, the bacterial suspension was inoculated in the 
wells containing MHB without PdB. The antimicrobial activity of plasma and CaCl2 was also measured. After 
incubation at 37 °C for 24 hours, the MIC values were determined as the lowest dilution in which no bacterial 
growth is visible. The test was performed in duplicate for each isolate and the test was repeated in case the MIC 
values for the two wells of each PdB differed39.
Time-kill assay. This method was performed in duplicate, by inoculating 5 × 105 (CFU/mL) of 
mid-logarithmic-phase bacterial cells into 2 mL of MHB. Immediately after platelets activation, 250 µL from PdB 
or the same volume of 0.9% saline and plasma (normal control) were added into the tubes containing 250 µL of 
MHB inoculated with the relevant strains. Cultures were incubated at 37 °C with shaking (200 rpm) and 50 µL 
of samples were removed at 0, 4 and 8 hours after the inoculation stage for bacterial counts. Then, each sample 
serially diluted 10-fold in 0.9% saline, then 10 µL of each sample was spread onto agar plates. Bacterial colonies 
were counted (CFU/mL) and repeated measures of the Kruskal-Wallis test were performed to determine the 
differences between the variables20.
Burn procedure. Forty-eight young male Wistar albino rats weighing 250–300 grams were divided randomly 
into four groups as follows: control group (n = 12) which was exposed to burn injury then infected by MRSA 
but received no treatment, F-PdB and CaCl2-PdB treated animals (n = 12, in each group) and the last group 
which was treated with plasma (n = 12). The animals were obtained 1 week before the experiment and kept in 
appropriate cages under controlled temperature (22 °C), humidity, lighting conditions (12-hour light/dark cycle), 
and had unrestricted access to food and water. Dorsal hair of rats was shaved with electric clippers and the rats 
were anesthetized by an intraperitoneal injection of 50 mg/kg ketamine hydrochloride and 10 mg/kg xylazine 
hydrochloride. Full-thickness, 5-mm diameter burn injury sites were generated using a calibrated bar with a 
temperature of 160 °C. The calibrated bar was applied to the dorsal shaved skin of the rats for 10 seconds (for both 
of the control and PdB–treated groups). Then, a suspension containing 5 × 108 MRSA cells was inoculated onto 
each wound and 24 hours after infection, 100 μl of each PdB, plasma, and saline were injected separately inside the 
infected lesions sites (each bio-material was injected into the lesion created in an animal) for 14 days. It should be 
noted that PdBs were injected every day due to the short lifetime of platelets. After experimentation, all rats were 
kept in special cages under controlled temperature and were fed with standard rat chow and water. Wound tissues 
were excised on days 3 and 7, homogenized in 10 ml PBS, serially diluted, and plated onto the MHA. Finally, the 
colony-forming units (CFUs) were quantified and analyzed for statistical significance using the Kruskal-Wallis 
test. Moreover, photographs were taken just after the burn induction and 4, 7 and 14 days later without removing 
the scab.
Measurement. On day 14, rats were euthanized under deep anesthesia (60 mg/kg intraperitoneal ketamine) 
and a fragment of the wound was excised and fixed in 10% formalin and paraffin-embedded. Afterward, the 
tissues were cut on a microtome into 4-micron vertical sections and were stained with hematoxylin and eosin 
(H&E). Finally, the wound healing hallmarks were measured using a light microscope; angiogenesis, polymor-
phonuclear leucocytes (PMNL), and re-epithelialization were observed and the images were captured without 
further processing15,25.
Indirect immunofluorescence. Rat skin samples (from four groups) were fixed in 4% neutral buffered 
formaldehyde, embedded in paraffin then cut on a microtome into 5 µm sections. The sections were mounted 
on glass slides coated with APES (Aminopropyl-tri-ethoxy-silane). After deparaffinization and rehydration of 
the slides using a range of xylene and graded ethanol, antigen retrieval was performed by boiling the slides in 
sodium citrate buffer (pH 6.0) and maintained at a sub-boiling temperature for 10 minutes using a microwave. 
After cooling the slides on the bench-top for 30 minutes the tissue sections were embedded in 3.0% hydrogen 
peroxide in methanol for 15 minutes to block endogenous peroxidase activity. To permeabilize the tissue sections 
they were preincubated with 1% bovine serum albumin (BSA) and 0.3% Triton X-100 in PBS at room temperature 
for 15 min. Subsequently, the sections were incubated for 2 hours at room temperature with the primary antibody 
(rabbit anti-collagen I antibody, diluted in PBS 1:100). After washing the slides with PBS for 10 minutes the tissue 
sections were incubated for another 2 hours at room temperature with the secondary antibody (Goat anti-rabbit 
IgG FITC, diluted in PBS 1:150). The stained sections were mounted with prolong gold antifade, containing DAPI 
for nuclear stain. Finally, the samples were assessed using a Labomed Lx400 fluorescent microscope equipped 
with an Olympus color view III camera40.
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